ID: ALA4474195

Max Phase: Preclinical

Molecular Formula: C5H10N2O2

Molecular Weight: 130.15

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)C1CCCNN1

Standard InChI:  InChI=1S/C5H10N2O2/c8-5(9)4-2-1-3-6-7-4/h4,6-7H,1-3H2,(H,8,9)

Standard InChI Key:  BZIBRGSBQKLEDC-UHFFFAOYSA-N

Associated Targets(Human)

Zinc finger protein GLI1 201 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Shh Light II 88 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 130.15Molecular Weight (Monoisotopic): 130.0742AlogP: -0.67#Rotatable Bonds: 1
Polar Surface Area: 61.36Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.06CX Basic pKa: 5.81CX LogP: -2.01CX LogD: -3.40
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.44Np Likeness Score: 0.85

References

1. Khatra H, Kundu J, Khan PP, Duttagupta I, Pattanayak S, Sinha S..  (2016)  Piperazic acid derivatives inhibit Gli1 in Hedgehog signaling pathway.,  26  (18): [PMID:27528433] [10.1016/j.bmcl.2016.08.008]

Source